1997
DOI: 10.1002/(sici)1097-0339(199712)17:6<487::aid-dc22>3.0.co;2-h
|View full text |Cite
|
Sign up to set email alerts
|

Fine-needle aspiration in metastatic glioblastoma multiforme

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 3 publications
0
1
0
Order By: Relevance
“…In the pediatric age group, parenchymal lesions such as supratentorial primitive neuroectodermal tumor, high-grade non-Hodgkin's lymphoma, malignant hemangiopericytoma, or lesions originating from the base of the skull, such as chondrosarcoma at the skull base, embryonal rhabdomyosarcoma, or small cell osteosarcoma, should be the other differentials. 11 12 13 14 15 That is why, IHC is important to distinguish between those diagnoses, but no proper Immunohistochemistry (IHC) patterns have been identified till now, which is characteristic of IEMC. However, it is almost always positive for vimentin and S-100 and negative for synaptophysin, chromogranin, and EMA, but occasionally positive for GFAP (25% of the time).…”
Section: Discussionmentioning
confidence: 99%
“…In the pediatric age group, parenchymal lesions such as supratentorial primitive neuroectodermal tumor, high-grade non-Hodgkin's lymphoma, malignant hemangiopericytoma, or lesions originating from the base of the skull, such as chondrosarcoma at the skull base, embryonal rhabdomyosarcoma, or small cell osteosarcoma, should be the other differentials. 11 12 13 14 15 That is why, IHC is important to distinguish between those diagnoses, but no proper Immunohistochemistry (IHC) patterns have been identified till now, which is characteristic of IEMC. However, it is almost always positive for vimentin and S-100 and negative for synaptophysin, chromogranin, and EMA, but occasionally positive for GFAP (25% of the time).…”
Section: Discussionmentioning
confidence: 99%